Doximity reported Q2 fiscal 2027 results

Item 2.02 – Results of Operations and Financial Condition

On November 5, 2026 , Doximity, Inc. ("Doximity") issued a press release announcing its financial results for its fiscal quarter ended September 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K¹ and is incorporated by reference herein.²

The information provided in this Item 2.02 of this Current Report on Form 8-K, and the Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 – Financial Statements and Exhibits

(d) Exhibits

Exhibit Number Description

99.1 Press Release entitled "Doximity Announces Fiscal 2027 Second Quarter Financial Results dated November 5, 2026"

104 Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 5, 2026

DOXIMITY, INC.

By:

/s/ Matthew Sonefeldt

Matthew Sonefeldt

Chief Financial Officer

Doximity Announces Fiscal 2027 Second Quarter Financial Results

Total revenues of $174.5 million, up 4% year-over-year³

Net income of $34.7 million, margin of 20%

Adjusted EBITDA of $88.9 million, margin of 51%

SAN FRANCISCO, Calif., November 5, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 second quarter ended September 30, 2026.

"We delivered another quarter of record engagement while investing heavily in AI and maintaining a 51% adjusted EBITDA margin," said Jeff Tangney, co-founder and CEO of Doximity. "More than 190 health systems have now purchased our AI suite, and with UpToDate and DoseCheck, we're extending our lead in distribution and trust."

Fiscal 2027 Second Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended September 30, 2025.

• Revenue: Revenue of $174.5 million, versus $168.5 million, an increase of 4% year-over-year.

• Net income and non-GAAP net income: Net income of $34.7 million, versus $62.1 million, representing a margin of 19.9%⁴, versus 36.8%. Non-GAAP net income of $68.3 million, versus $90.0 million, representing a margin of 39.1%, versus 53.4%.

• Adjusted EBITDA: Adjusted EBITDA of $88.9 million, versus $100.8 million, a decrease of 12% year-over-year, representing adjusted EBITDA margins of 50.9%⁵, versus 59.8%.

• Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.18, versus $0.31, while non-GAAP diluted net income per share was $0.36, versus $0.45.

• Operating cash flow and free cash flow : Operating cash flow of $93.3 million, versus $93.9 million, a decrease of 1% year-over-year, and free cash flow of $91.3 million, versus $91.6 million, a decrease of less than 1% year-over-year.

Financial Outlook

Doximity is providing guidance for its fiscal third quarter ending December 31, 2026 as follows:

• Revenue between $195 million and $196 million.

• Adjusted EBITDA between $102.5 million and $103.5 million.

Doximity is updating guidance for its fiscal year ending March 31, 2027 as follows:

• Revenue between $678 million and $683 million.

• Adjusted EBITDA between $317 million and $325 million.

For more detailed financial commentary, please refer to the "Modeling Considerations" appendix in our prepared remarks.

1

Conference Call Information

Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com. The recorded webcast will be available on the Company's Investor Relations page shortly after the call.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 85% of U.S. physicians. With AI-powered clinical reference and search capabilities, Doximity helps doctors access trusted, peer-reviewed information and medical literature. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Forward-looking statements are all statements other than statements of historical fact, and specifically include statements regarding guidance and future business and financial results. These statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including, without limitation, those set forth in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management's beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Investor Relations Contact:

Perry Gold

ir@doximity.com

Media Contact:

Richard George

pr@doximity.com

2

DOXIMITY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands) (unaudited)

September 30, 2026 Ma